Company Filing History:
1 out of 3 
1 out of 12 Years Active: 2021
Title: Damian Garbicz: Innovator in Medical Diagnostics
Introduction
Damian Garbicz is a notable inventor based in Radomysl, Poland. He has made significant contributions to the field of medical diagnostics, particularly in the area of nephrology. His innovative work focuses on the use of urine proteins as markers for diagnosing IgA nephropathy.
Latest Patents
Garbicz holds a patent for a method titled "Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy." This method utilizes a combination of alpha-1B-glycoprotein (A1BG), orosomucoid 1 (ORMI), and Ig lambda-2 chain C regions (IGLC2) as protein markers in urine samples. This innovative approach aims to improve the diagnosis of IgA nephropathy, a kidney disorder that can lead to serious health complications.
Career Highlights
Throughout his career, Garbicz has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and the Medical University of Warsaw. His experience in these organizations has allowed him to develop and refine his diagnostic methods, contributing to advancements in medical research and patient care.
Collaborations
Garbicz has collaborated with notable colleagues, including Krzysztof Mucha and Leszek Paczek. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical diagnostics.
Conclusion
Damian Garbicz's contributions to the field of medical diagnostics, particularly through his patent on urine protein markers for IgA nephropathy, highlight his role as an innovator. His work continues to impact the medical community and improve patient outcomes.